NLRP3 and atrial fibrillation: In this context, the NLRP3 inflammasome, which is expressed in cardiomyocytes and cardiac fibroblasts, has been identified as playing a key role in the development of HF and AF, making patients with pre-existing HFrEF the focus of numerous clinical studies exploring intervention strategies at this level.